Skip to main content
. 2018 Feb 14;142(12):2610–2620. doi: 10.1002/ijc.31286

Figure 1.

Figure 1

Overall survival (a) and progression free survival (b) of 2,913 metastatic sarcoma patients receiving first‐line chemotherapy with lung lesions only, other lesions only, or both types of lesions. [Color figure can be viewed at wileyonlinelibrary.com]